These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 4449973)
1. The dynamic confrontation model as an integration of psychotherapy. Hausner M Psychother Psychosom; 1974; 24(4-6):497-9. PubMed ID: 4449973 [No Abstract] [Full Text] [Related]
2. Psychedelic drugs. Rinkel M Am J Psychiatry; 1966 Jun; 122(12):1415-6. PubMed ID: 5929494 [No Abstract] [Full Text] [Related]
3. Psychotomimetic agents. Cohen S Annu Rev Pharmacol; 1967; 7():301-18. PubMed ID: 5337083 [No Abstract] [Full Text] [Related]
4. THE PSYCHOTOMIMETIC DRUGS. AN OVERVIEW. COLE JO; KATZ MM JAMA; 1964 Mar; 187():758-61. PubMed ID: 14094299 [No Abstract] [Full Text] [Related]
5. [Hallucinogenic drugs and the psychopharmacology of the conditioned reflex]. Sivadjian J Therapie; 1970; 25(6):1059-66. PubMed ID: 5509533 [No Abstract] [Full Text] [Related]
6. Continuity of fantasy: dreams and dreaming in the arts. Gotthelf T Exp Med Surg; 1969; 27(1-2):3-12. PubMed ID: 4188969 [No Abstract] [Full Text] [Related]
8. Hallucinogenic drugs in psychiatric research and treatment. Perspectives and prospects. Strassman RJ J Nerv Ment Dis; 1995 Mar; 183(3):127-38. PubMed ID: 7891058 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of 3,4-methylenedioxyamphetamine (MDA) as an adjunct to psychotherapy. Naranjo C; Shulgin AT; Sargent T Med Pharmacol Exp Int J Exp Med; 1967; 17(4):359-64. PubMed ID: 5631047 [No Abstract] [Full Text] [Related]
11. Alterations in consciousness produced by combinations of LSD, hypnosis and psychotherapy. Levine J; Ludwig AM Psychopharmacologia; 1965 Feb; 7(2):123-37. PubMed ID: 5830970 [No Abstract] [Full Text] [Related]
12. The psychopharmacology of hallucinogenic agents. Freedman DX Annu Rev Med; 1969; 20():409-18. PubMed ID: 4894506 [No Abstract] [Full Text] [Related]
14. Stimulus properties of phenethylamine hallucinogens and lysergic acid diethylamide: the role of 5-hydroxytryptamine. Winter JC J Pharmacol Exp Ther; 1978 Feb; 204(2):416-23. PubMed ID: 621672 [No Abstract] [Full Text] [Related]
15. Dynamics of psychedelic drug abuse. A clinical study. Bowers M; Chipman A; Schwartz A; Dann OT Arch Gen Psychiatry; 1967 May; 16(5):560-6. PubMed ID: 5337259 [No Abstract] [Full Text] [Related]
16. [Problems of psychotoxicology (a review of the literature)]. Spivak LI; Mil'shteĭn GI Voen Med Zh; 1973 Oct; 10():40-4. PubMed ID: 4786146 [No Abstract] [Full Text] [Related]
17. An electrographic study of d-lysergic acid diethylamide and nine congeners. Schweigerdt AK; Stewart AH; Himwich HE J Pharmacol Exp Ther; 1966 Mar; 151(3):353-9. PubMed ID: 5938474 [No Abstract] [Full Text] [Related]
18. Clinical observations of simultaneous hallucinogen administration in identical twins. WILKENS B; MALITZ S; ESECOVER H Am J Psychiatry; 1962 Mar; 118():815-8. PubMed ID: 14007020 [No Abstract] [Full Text] [Related]
19. The use of animal tests to predict behavioural effects of chemicals on man. Brimblecombe RW Ciba Found Study Group; 1970; 35():6-24. PubMed ID: 5525681 [No Abstract] [Full Text] [Related]